- August 4, 2016 | BY
How a Reproducibility Network—and CROs—might help us produce better drugs for tough diseases like AD.
- August 3, 2016 | BY
In recognition of the enormous value of LAL to world health, we must question if there is a need to limit the number of HSCs required to produce LAL.
- July 29, 2016 | BY
A Nasal Weapon, How Brexit Affects Science (Abstract Science: July 25-29)
- July 27, 2016 | BY
We’re mostly microbes, so let’s treat them with a little respect. Our lives depend upon it. A Q&A with immunotoxicologist Rodney Dietert.
- July 25, 2016 | BY
Emerging methods for the testing of adventitious agents.
- July 22, 2016 | BY
Utah’s weird Zika case, an experimental cancer drug’s utility in heart disease, and a bigger window into the brain.
- July 19, 2016 | BY
Playing political games at the expense of a global public health crisis.
- July 18, 2016 | BY
Life Sciences offer the unprecedented chance to make the currency of innovation available to all Americans.
- July 15, 2016 | BY
FDA resumes cancer trial, mice regain partial vision and a CDC assessment of the Zika threat for Olympic-bound individuals.
- July 11, 2016 | BY
The complicated world of fungi provides a valuable lesson about messy curating. Micro-Phyles Case No. 2.